CD86 and systemic lupus erythematosus: The percentages of pDCs expressing Ki67, CD86, and CD80, hallmarks of TLR-induced pDC activation (McKenna et al., 2005), were significantly increased in SLE patients with active disease compared to inactive patients or healthy controls (Figures 4B–4E).